Docherty J R, Warnock P
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin.
J Cardiovasc Pharmacol. 1987;10 Suppl 3:S59-61.
In pithed spontaneously hypertensive rats (SHR), the selective 5-HT2-receptor antagonist LY 53857 (1 mg/kg) had no effect on alpha 1- or alpha 2-adrenoceptors, but ketanserin (1 mg/kg) had some potency as an alpha 1-adrenoceptor antagonist, being approximately 100 times less potent than prazosin. Both ketanserin and LY 53857 (0.01 mg/kg) markedly antagonized the pressor response to 5-HT. In anesthetised SHR, both ketanserin and LY 53857 (1 mg/kg) significantly lowered diastolic blood pressure (DBP) alone or subsequent to administration of prazosin (1 mg/kg). In conscious SHR, LY 53857 (1 mg/kg) and ketanserin (0.1 mg/kg) did not significantly affect DBP, but ketanserin (1 mg/kg) significantly lowered DBP. It is concluded that ketanserin lowers DBP in conscious SHR mainly by alpha 1-adrenoceptor blockade, but that in anaesthetised SHR additional actions, possibly 5-HT2 blockade, contribute to the blood pressure lowering effects.
在脊髓横断的自发性高血压大鼠(SHR)中,选择性5-羟色胺2(5-HT2)受体拮抗剂LY 53857(1毫克/千克)对α1或α2肾上腺素能受体无作用,但酮色林(1毫克/千克)作为α1肾上腺素能受体拮抗剂有一定效力,其效力比哌唑嗪约低100倍。酮色林和LY 53857(0.01毫克/千克)均能显著拮抗对5-羟色胺的升压反应。在麻醉的SHR中,酮色林和LY 53857(1毫克/千克)单独或在给予哌唑嗪(1毫克/千克)后均能显著降低舒张压(DBP)。在清醒的SHR中,LY 53857(1毫克/千克)和酮色林(0.1毫克/千克)对DBP无显著影响,但酮色林(1毫克/千克)能显著降低DBP。结论是,酮色林在清醒的SHR中主要通过阻断α1肾上腺素能受体降低DBP,但在麻醉的SHR中,其他作用(可能是阻断5-HT2)有助于降低血压。